Keyphrases
Tumor Necrosis Factor-α
100%
Steady State
100%
Hemodynamic Effects
100%
L-NAME
100%
Nitric Oxide Synthase Inhibition
100%
End-diastolic Volume
66%
Left Ventricle
50%
Pressure-volume
50%
Angiotensin II (Ang II)
33%
Myocardial Dysfunction
33%
Contractility
33%
Afterload
33%
Stroke Work
33%
Ventricular Performance
33%
Nitro
16%
Size Dependence
16%
Systolic Pressure
16%
End-systolic Pressure
16%
Left Ventricular Systolic Function
16%
Attendants
16%
Ventricular Dysfunction
16%
Arginine
16%
Vasodilation
16%
Nitric Oxide
16%
Bolus
16%
Coronary Blood Flow
16%
Control Condition
16%
Methyl Ester
16%
Isovolumic Relaxation
16%
Conscious Dogs
16%
Velocity-dependent
16%
Velocity-based
16%
Recombinant Human Tumor Necrosis Factor
16%
Force-based
16%
Relaxation-based
16%
Biochemistry, Genetics and Molecular Biology
Tumor Necrosis Factor
100%
Steady State
100%
Hemodynamic
100%
Nitric Oxide Synthase
100%
Systolic Blood Pressure
50%
Muscle Contractility
50%
Heart Afterload
50%
Heart Ventricle Performance
50%
Angiotensin
50%
Mediator
25%
Heart Ventricle Function
25%
Coronary Artery Blood Flow
25%
Vasodilatation
25%
Heart Left Ventricle Pressure
25%
Nitric Oxide
25%
Arginine
25%
Veterinary Science and Veterinary Medicine
Dog
100%
Hemodynamic
100%
Neoplasm
100%
End-Diastolic Volume
66%
Contractility
33%
Afterload
33%
Angiotensin
33%
Vasodilation
16%
Neuroscience
Necrosis
100%
Nitric Oxide Synthase
100%
End-Diastolic Volume
100%
Angiotensin II
50%
Cerebrovascular Accident
50%
Arginine
25%
Nitric Oxide
25%
Vasodilation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Nitric Oxide Synthase
100%
Angiotensin II
50%
Cerebrovascular Accident
50%
Arginine
25%
Nitric Oxide
25%
Psychology
Systolic Blood Pressure
100%